Pension Plan Funding: M&A’S Poison Pill
12 Pages Posted: 8 Mar 2012
Date Written: 2007
Abstract
This study examines the role of pension plan funding status on merger and acquisition (M&A) activity across a large sample of UK corporations. We explore how corporate activity in the M&A market is linked to the funding status of defined benefit pension plans. Pension deficits have a negative impact on the likelihood of firms being acquired, suggesting pension deficits act as a poison pill.
Keywords: M&A, Pension Plan Funding, Count Data Model
Suggested Citation: Suggested Citation
Do you have negative results from your research you’d like to share?
Recommended Papers
-
New Evidence and Perspectives on Mergers
By Gregor Andrade, Mark L. Mitchell, ...
-
Do Managerial Objectives Drive Bad Acquisitions?
By Randall Morck, Andrei Shleifer, ...
-
Stock Market Driven Acquisitions
By Andrei Shleifer and Robert W. Vishny
-
Stock Market Driven Acquisitions
By Andrei Shleifer and Robert W. Vishny
-
Poison or Placebo? Evidence on the Deterrent and Wealth Effects of Modern Antitakeover Measures
By Robert Comment and G. William Schwert
-
Does Corporate Performance Improve after Mergers?
By Paul M. Healy, Krishna Palepu, ...
-
Managerial Performance, Tobin's Q, and the Gains from Successful Tender Offers
By Larry H.p. Lang, Ralph A. Walkling, ...